MissionIR Articles
-
ADVENTRX Pharmaceuticals, Inc. (ANX) Starts Presentation at the OneMedForum 2013 Conference
ADVENTRX Pharmaceuticals is a biopharmaceutical company engaged in the development of proprietary product candidates for treating various diseases and conditions. ANX-188, the company’s lead product candidate, is initially being developed as a treatment for complications…
-
NanoViricides, Inc. (NNVC) Starts Presentation at the OneMedForum 2013 Conference
NanoViricides is a development-stage company engaged in creating special purpose nanomaterials for antiviral therapy. The company’s novel nanoviricide class of drug candidates is designed for the specific purpose of attacking and dismantling enveloped virus particles.…
-
DreamTeamGroup Gears Up for OneMedForum Conference
DreamTeamGroup, a consortium of unique marketing brands targeted toward investors, will be participating in the sixth annual OneMedForum Conference, taking place Jan. 7-9, 2013, at the Sir Francis Drake Hotel in San Francisco, Calif. The…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Reports 2025 Results, Revenue Growth Driven by Mudra Gesture-Control Wearables
- MissionIRNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Partners with TYTL to Scale Tokenized Residential Real Estate Equity Platform
- Olenox Industries Inc. (NASDAQ: OLOX) Advances Well Revitalization Program as Production Stabilizes in Texas Fields
- MissionIRNewsBreaks – Versus Systems Inc. (NASDAQ: VS) Renews Texas Rangers Partnership For Filter Fan Cam Through 2026 Season
- MissionIRNewsBreaks – TYTL Corp Closes Seed Funding Round, Announces Partnerships With Beeline Holdings (NASDAQ: BLNE) And Anchorage Digital